Valuation: Hugel, Inc.

Market Cap 2,901B 2.05B 1.78B 1.67B 1.52B 2.86B 196B 2.91B 19.53B 7.65B 98.03B 7.71B 7.54B 327B P/E 2026 *
20.1x
P/E 2027 * 15.8x
Enterprise Value 2.34B 1.66M 1.44M 1.35M 1.23M 2.31M 158M 2.35M 15.77M 6.18M 79.15M 6.23M 6.09M 264M EV / Sales 2026 *
4.46x
EV / Sales 2027 * 3.44x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day+1.07%
1 week+9.50%
Current month+21.51%
1 month+17.46%
3 months-4.24%
6 months-1.22%
Current year+22.56%
1 week 261,000
Extreme 261000
295,000
1 month 216,500
Extreme 216500
295,000
Current year 216,500
Extreme 216500
308,500
1 year 208,500
Extreme 208500
342,000
3 years 106,400
Extreme 106400
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 29/04/2022
Director/Board Member 56 29/04/2022
Director/Board Member 51 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
5/20/25 A Fiscal year 1,200 0.0095%
5/20/25 A Sell 1,200 0.0095%
5/19/25 A Fiscal year

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%+9.50%-19.05%+145.87% 2.16B
-1.37%+4.78%+45.99%-1.23% 79.58B
+2.55%+9.01%+1.40%+30.65% 52.73B
-2.39%-3.71%+17.99%+168.69% 49.77B
+0.08%+5.95%-47.62%-47.36% 46.77B
-1.56%-2.19%+59.29%-25.50% 30.13B
-0.39%+0.39%+52.89%+83.63% 24.54B
+1.27%+6.28%+137.81%-40.32% 24.18B
0.00%+5.81%+9.45%+194.91% 21.2B
-1.15%+1.99%+73.51%+169.39% 16.36B
Average -0.11%+4.67%+33.16%+67.87% 34.74B
Weighted average by Cap. -0.41%+4.52%+29.30%+43.82%

Financials

2026 *2027 *
Net sales 526B 372M 322M 302M 275M 518M 35.49B 527M 3.54B 1.39B 17.77B 1.4B 1.37B 59.27B 639B 453M 392M 367M 335M 630M 43.16B 641M 4.31B 1.69B 21.61B 1.7B 1.66B 72.08B
Net income 171B 121M 105M 98.1M 89.51M 168M 11.53B 171M 1.15B 451M 5.77B 454M 444M 19.26B 220B 156M 135M 126M 115M 217M 14.85B 220M 1.48B 580M 7.43B 584M 572M 24.79B
Net Debt -559B -395M -343M -321M -293M -551M -37.72B -560M -3.76B -1.47B -18.88B -1.48B -1.45B -62.99B -705B -499M -432M -405M -369M -695M -47.57B -706M -4.74B -1.86B -23.81B -1.87B -1.83B -79.44B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
604
Date Price Change Volume
11/08/26 ₩282,500.00 +1.07% 68,315
10/08/26 ₩279,500.00 +2.19% 71,938
07/08/26 ₩273,500.00 -1.97% 96,138
06/08/26 ₩279,000.00 +7.31% 123,618
05/08/26 ₩260,000.00 +0.78% 38,984
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
282,500.00KRW
Average target price
369,312.50KRW
Spread / Average Target
+30.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock